AGEM symposia

AGEM webinar series

Owning Obesity & Negating NASH:

Awesome Assignments for the 21st century

Hosted by dr. Onno Holleboom and dr. Eveline Bruinstroop
Organized by Onno Holleboom, Victor Gerdes, Eveline Bruinstroop, Anne-Marieke van Dijk, Anne Linde Mak and Eva Dirkx


You don't have to register for this webinar series. The webinars are freely accesible using the links and passcodes below.

If you register you will receive a reminder of the episodes and the link to the ZOOM the day before the episodes take place.
If you already registered for the symposium planned on November 5th, you will automatically receive the reminders, so you don't have to register again.

Register here to receive reminders!


Mechanisms driving NASH 

THURSDAY, November 5, 2020

15:30h - 17:00h
Via ZOOM: link to meeting 
Meeting ID: 883 1959 3005
Passcode: 300119

Prof. Anna Mae Diehl
Hepatologist, Professor of Medicine in Molecular Genetics and Microbiology
Duke Cancer Institute, USA

"Fixing Fatty Livers"

Prof. Diehl leads basic and translational research programs in fatty liver diseases. Her research has advanced understanding about mechanisms that control the pathogenesis of these diseases and that determine whether or not they progress to cirrhosis and liver cancer.

Prof. Ronit Shiri-Sverdlov
Professor of Medicine in Hepatic Inflammation and Metabolic Health
Maastricht University

"Far beyond lysosomes: role of cathepsin D in NAFLD"

Prof. Ronit Shiri-Sverdlov is focusing on exploring the molecular links between lipids and inflammation in a variety of metabolic diseases. Her recent translational work is related to the role of lysosomal enzymes in metabolic and inflammatory pathways with the aim to establish novel diagnostic tools and treatment options for NASH, T2D and cancer.


Mechanisms driving insulin resistance and obesity 

THURSDAY, November 12, 2020

15:30h - 17:00h
Via ZOOM: link to meeting  
Meeting ID: 861 0188 0764
Passcode: 444382

Prof. Mireille Serlie
Professor of Medicine (Nutrition and Energy Metabolism)
Amsterdam University Medical Centers

"Molecular Pathways in NAFLD and Insulin Resistance"

Prof. Mireille Serlie’s lab seeks to understand molecular mechanisms of insulin resistance in humans. Her lab also focusses on the role of nutrients and obesity on the central control of metabolism and food intake. Her studies are translational and involve in depth analysis of metabolic fluxes and brain imaging.

Prof. Marc-Emmanuel Dumas
Professor and Chair of Systems Medicine
Imperial College, London

“The microbiome as a NAFLD/MAFLD target”

The research of prof. Marc-Emmanuel Dumas on metabolic and systems medicine focusses on the integration of metabolomic data with other "omics” to identify metabolites and genes associated with cardiometabolic diseases, inflammation, ageing, and cancer to form and test novel hypotheses for the understanding the complex variation of the gene, protein and metabolic networks generated by such pathologies.


Clinical insights in NAFLD 

THURSDAY, November 19, 2020

15:30h - 17:00h
Via ZOOM: link to meeting    
Meeting ID: 815 6338 5915
Passcode: 951576

Dr. Cyrielle Caussy
Associate Professor of Nutrition and Endocrinologist
Hospices Civils de Lyon, Lyon 1 University

"High risk population for NAFLD: should we screen for advanced fibrosis?"

Dr Caussy’s main field of research interests are insulin resistance and nonalcoholic fatty liver disease (NAFLD). She has a specific interest in non-invasive biomarkers and pathophysiology of NAFLD especially in high-risk populations such as type 2 diabetes and obese patients.

Dr. Maarten Tushuizen
Leiden University Medical Center

"Care paths in NAFLD: why, who, where, when and how"

Dr. Maarten Tushuizen's research focusses on NAFLD/NASH, principally development of clinical care paths including diagnostics, surveillance and treatment. Furthermore, his interests are the various aspects (including prevention) of NAFLD/NASH before and after liver transplantation, including posttransplantation diabetes mellitus, hepatocellular carcinoma and cardiovascular disease risk.


Owning obesity & negating NASH 

THURSDAY, November 26, 2020

15:30h - 17:00h
Via ZOOM: link to meeting     
Meeting ID: 886 8548 5340
Passcode: 052368

Prof. Saskia van Mil
Professor of Molecular and Translational Metabolism
University of Utrecht

"Should we selectively target the FXRα2 isoform to improve NASH therapy?"

The research group of Prof. Saskia van Mil investigates the role of bile acid metabolism and the farnesoid X receptor (FXR) in liver energy metabolism. Using the new knowledge obtained, they aim to increase selectivity and efficacy of targeting FXR for NASH.

Dr. Victor Gerdes
Internist at the Department of Vascular Medicine
Amsterdam University Medical Centers

"The treatment of obesity: current options and future perspectives"

Dr. Gerdes is internist at the Department of Vascular Medicine. Being closely involved in the bariatric surgery program at Spaane Gasthuis in Hoofddorp, he has a longstanding interest in obesity and a research line on the metabolic consequences of obesity and the metabolic changes that bariatric surgery induces in liver and gut microbiome.

Do you want to organize an AGEM symposium?

The following are the conditions under which you can get financial and organizational support of AGEM to organize a symposium:

  • The subject of the symposium is interesting for (most of) the AGEM researchers
  • The symposium will be held at an location in Amsterdam; this may be at one of the Amsterdam UMC locations, but also outside of the Amsterdam UMC
  • The symposium is free of charge for all AGEM and Amsterdam UMC researchers
  • Attendees from outside are welcome, but in case of limited space AGEM researchers have priority
  • AGEM is involved in the organization of the symposium:

    • AGEM is involved in making the program
    • AGEM is involved in choosing invited speakers
  • Announcements regarding the symposium will be made by AGEM
  • AGEM contributes up to EUR 10.000,-
  • AGEM has to approve the global format of the symposium before financial and organizational support will be given.

Please contact AGEM at to find out whether AGEM can support your symposium!

For AGEM symposia from previous years see:

AGEM symposia 2019
AGEM symposia 2018
AGEM symposium 2017